The Food and Drug Administration said Monday an advisory panel would meet June 15 to discuss use of the vaccines developed by Pfizer and German partner BioNTech, as well as the one developed by Moderna, in children aged 6 months to four years old.

Topics:  food   drug administration   june   pfizer   german   biontech   moderna in   panel   vaccines   month   years   children aged   developed   
BING NEWS:
  • FDA delays decision on Moderna RSV vaccine
    The regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
    05/10/2024 - 5:31 am | View Link
  • FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It
    The Food and Drug Administration (FDA) notified Moderna Inc (NASDAQ:MRNA) on Friday that its review of a new vaccine has been delayed. The agency, citing administrative constraints, does not expect to ...
    05/10/2024 - 2:27 am | View Link
  • US FDA pushes decision on Moderna's RSV vaccine to end of this month
    opens new tab respiratory syncytial virus (RSV) vaccine due to some "administrative constraints" and will complete the review ... the FDA and recommended for use by the CDC, Moderna's shot will ...
    05/10/2024 - 12:29 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News